Chen Zhilin, Feng Ruifa, Kahlert Ulf Dietrich, Chen Zhitong, Torres-Dela Roche Luz Angela, Soliman Amr, Miao Chen, De Wilde Rudy Leon, Shi Wenjie
Department of Breast and Thoracic Oncological Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, China.
University Hospital for Gynecology, Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germany.
Front Oncol. 2022 Jun 9;12:883197. doi: 10.3389/fonc.2022.883197. eCollection 2022.
The infiltration of CD8 T cells is usually linked to a favorable prognosis and may predict the therapeutic response of breast cancer patients to immunotherapy. The purpose of this research is to investigate the competing endogenous RNA (ceRNA) network correlated with the infiltration of CD8 T cells.
Based on expression profiles, CD8 T cell abundances for each breast cancer (BC) patient were inferred using the bioinformatic method by immune markers and expression profiles. We were able to extract the differentially expressed RNAs (DEmRNAs, DEmiRNAs, and DElncRNAs) between low and high CD8 T-cell samples. The ceRNA network was constructed using Cytoscape. Machine learning models were built by lncRNAs to predict CD8 T-cell abundances. The lncRNAs were used to develop a prognostic model that could predict the survival rates of BC patients. The expression of selected lncRNA (XIST) was validated by quantitative real-time PCR (qRT-PCR).
A total of 1,599 DElncRNAs, 89 DEmiRNAs, and 1,794 DEmRNAs between high and low CD8 T-cell groups were obtained. Two ceRNA networks that have positive or negative correlations with CD8 T cells were built. Among the two ceRNA networks, nine lncRNAs (MIR29B2CHG, NEAT1, MALAT1, LINC00943, LINC01146, AC092718.4, AC005332.4, NORAD, and XIST) were selected for model construction. Among six prevalent machine learning models, artificial neural networks performed best, with an area under the curve (AUC) of 0.855. Patients from the high-risk category with BC had a lower survival rate compared to those from the low-risk group. The qRT-PCR results revealed significantly reduced XIST expression in normal breast samples, which was consistent with our integrated analysis.
These results potentially provide insights into the ceRNA networks linked with T-cell infiltration and provide accurate models for T-cell prediction.
CD8 T细胞浸润通常与良好的预后相关,并且可能预测乳腺癌患者对免疫疗法的治疗反应。本研究的目的是调查与CD8 T细胞浸润相关的竞争性内源性RNA(ceRNA)网络。
基于表达谱,通过免疫标志物和表达谱,使用生物信息学方法推断每个乳腺癌(BC)患者的CD8 T细胞丰度。我们能够提取低CD8 T细胞样本和高CD8 T细胞样本之间差异表达的RNA(DEmRNA、DEmiRNA和DElncRNA)。使用Cytoscape构建ceRNA网络。通过lncRNA构建机器学习模型以预测CD8 T细胞丰度。lncRNA用于开发可预测BC患者生存率的预后模型。通过定量实时PCR(qRT-PCR)验证所选lncRNA(XIST)的表达。
在高CD8 T细胞组和低CD8 T细胞组之间共获得1599个DElncRNA、89个DEmiRNA和1794个DEmRNA。构建了与CD8 T细胞具有正相关或负相关的两个ceRNA网络。在这两个ceRNA网络中,选择了9个lncRNA(MIR29B2CHG、NEAT1、MALAT1、LINC00943、LINC01146、AC092718.4、AC005332.4、NORAD和XIST)用于模型构建。在六种常见的机器学习模型中,人工神经网络表现最佳,曲线下面积(AUC)为0.855。与低风险组的BC患者相比,高风险组的患者生存率较低。qRT-PCR结果显示正常乳腺样本中XIST表达显著降低,这与我们的综合分析一致。
这些结果可能为与T细胞浸润相关的ceRNA网络提供见解,并为T细胞预测提供准确模型。